 |
AX66511 |
N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-9Z-octadecenamide |
1292769-40-4 |
C42H79NO11S |
806.1418 |
VIEW DETAILS > |
 |
AX66510 |
N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-octadecanamide |
244215-65-4 |
C42H81NO11S |
808.1576 |
VIEW DETAILS > |
 |
AX66523 |
2-amino-N-[(1S,2R,3E)-1-[[(O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-acetamide |
1360882-59-2 |
C38H70N2O18 |
842.965 |
VIEW DETAILS > |
 |
AX66524 |
N-[(1S)-2R-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3E-heptadecen-1-yl]-15Z-tetracosenamide |
151057-28-2 |
C48H91NO11S |
890.3012400000006 |
VIEW DETAILS > |
 |
AX66765 |
(3β)-[6-[[(2S)-2-amino-(5α)-[(aminoiminomethyl)amino]-1-oxopentyl]amino]hexanoate],cholestan-3-ol,bis(2,2,2-trifluoroacetate) |
1609010-59-4 |
C43H73F6N5O7 |
886.0594 |
VIEW DETAILS > |
 |
AX66756 |
[S-[R*,S*-(E,Z,Z,Z)]]-15-hydroperoxy-5,8,11,13-eicosatetraenoicacid,2-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-1-[[(1-oxooctadecyl)oxy]methyl]ethylester |
154436-49-4 |
C43H78NO10P |
800.0539 |
VIEW DETAILS > |
 |
AX66757 |
cholest-5-en-3-ol(3β)-3-[6-[[(2S)-2-amino-5-[(aminoiminomethyl)amino]-1-oxopentyl]amino]hexanoate],2,2,2-trifluoroacetate(1:2) |
1609010-56-1 |
C43H71F6N5O7 |
884.0436 |
VIEW DETAILS > |
 |
AX67591 |
1-Butyl-4-[4-(1-butyl-2,6-diphenylpyridin-1-ium-4-yl)phenyl]-2,6-diphenylpyridin-1-ium bis(tetrafluoroboranuide) |
121188-20-3 |
C48H46B2F8N2 |
824.5015 |
VIEW DETAILS > |
 |
AX82578 |
3-{4-[1,5-Bis(3,4-dimethoxyphenyl)-1,5-dioxopentan-3-yl]phenyl}-1,5-bis(3,4-dimethoxyphenyl)pentane-1,5-dione |
15775-88-9 |
C48H50O12 |
818.9034 |
VIEW DETAILS > |
 |
AY06685 |
Glp-1 Receptor Agonist 1 |
2212020-52-3 |
C48H48F2N10O5 |
882.9555 |
VIEW DETAILS > |